Orange Book Blog: Mylan, Apotex, and Teva File Motions Challenging FDA's Decision on Generic Norvasc

Orange Book Blog: Mylan, Apotex, and Teva File Motions Challenging FDA's Decision on Generic Norvasc: "Apparently not too many companies other than Pfizer are happy with the FDA's decision last week regarding Norvasc (amlodipine besylate) exclusivity. On Monday, Mylan, Apotex, and Teva all filed motions with the U.S. District Court for the District of Columbia for injunctive relief from FDA's decision. Today, everyone filed briefs in opposition to each others' motions."